Photograph by Adrienne Surprenant Press release Press release | 02 December 2021 Malaria MSF responds to Gavi board approving investment in malaria vaccine rollout 3 min
Press release Press release | 29 November 2021 COVID-19 In the wake of postponement of WTO’s Ministerial, MSF underscores the urgency of adopting the TRIPS Waiver for people’s unhindered access to COVID-19 medical tools 4 min
Photograph by Pablo Garrigos Press release Press release | 23 November 2021 COVID-19 MSF welcomes the first open license of a COVID-19 test to WHO COVID-19 Technology Access Pool 4 min
Photograph by Paul Odongo Press release Press release | 16 November 2021 COVID-19 MSF response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid 4 min
Photograph by Chris Allan Press release Press release | 04 November 2021 COVID-19 As Moderna releases astronomical Q3 sales figures, MSF tells the corporation it’s high time to share the technology with WHO mRNA vaccine tech transfer Hub in South Africa 5 min
Photograph by Mariana Abdalla Press release Press release | 04 November 2021 COVID-19 MSF response to first regulatory approval of first oral antiviral treatment for COVID-19, molnupiravir 2 min
Photo by Tracy Makhlouf/MSF Press release Press release | 27 October 2021 COVID-19 MSF responds to BioNTech’s announcement that it will establish production facilities in African countries 3 min
Photo by Mariana Abdalla/MSF Press release Press release | 27 October 2021 COVID-19 License between Merck and Medicines Patent Pool for global production of promising new COVID-19 drug molnupiravir disappoints in its access limitations 4 min
